The University of California, San Diego (UCSD) provides a wide range of research opportunities available to fellows. Each fellow has a faculty advisor, a research mentor and a scholarly oversight committee to advise and oversee the fellow's development into a scientific investigator.
Fellows can develop their research interests in basic science and translational science in the laboratories at:
University of California, San Diego
UCSD-Moores Cancer Center
La Jolla Institute for Allergy and Immunology (LJI)
Sanford-Burnham-Prebys Medical Research Institute
Scripps Research Institute
Fellows interested in developing a clinical research project are able to be part of UCSD's
Clinical Research Enhancement through Supplemental Training (CREST) Program. Through this program the fellow gains the knowledge needed to conduct clinical research and identifies a research mentor with experience in guiding trainees to a successful career in clinical research.
|Prognostic Factors for Venous Occlusion in Children with Venous Thromboembolism|
Amy Lovejoy, M.D.
|The role of PTEN and PI3K in neuroblastoma sensitivity to PI3K/c-Raf inhibitors and their potential as a therapeutic approach for relapsed patients|
Don Durden, M.D., Ph.D.
UCSD Moores Cancer Center
|Racial/Ethnic Diversity in Pediatric Oncology Clinical Trial Enrollment at Rady Children's Hospital San Diego|
Elena Martinez, Ph.D.
UCSD Moores Cancer Center
|Vitronectin, Integrin β3, and Phospho-Raf1 (ser338) Expression as Markers for Tumorigenicity in Pediatric Brain Tumors|
David Cheresh, Ph.D.
|Dissecting the Molecular Basis of Ewing Sarcoma Metastasis|
Jing Yang, Ph.D.
|Markers of activation in iNKT cells of Human Sickle Cell Disease in vitro and in vivo|
Joel Linden, Ph.D.
Personalized medicine for medulloblastoma: Screening patient derived xenografts to find sub-group specific therapies
Robert Wechsler-Reya, PhD
Sanford Burnham Prebys Medical Discovery Institute
|Impaired Clinical Outcomes Associated with Decreased Thymic T Cell Production in Pediatric Hematopoietic Stem Cell Transplant Patients|
Gerald Morris, M.D. Ph.D., UCSD
|Molecular Mechanisms of T-Cell Exhaustion in Cancer||Anjana Rao, Ph.D.|
|A. Preethi Ganesan |
|Tissue-resident memory features are linked to the magnitude of cytotoxic T-cell responses in human lung cancer||Nunzio Bottini, M.D., Ph.D.,|
|Ksenya Shliakhtsitsava |
|Age and cancer treatment are related to receiving treatment summaries and survivorship care plans in female young adult cancer survivors.||Ron Newfield, M.D.|
|Dual Mechanisms of necroptosis resistance in Neuroblastoma ||Robert Newbury, M.D.|
|Lauge Farnaes |
|Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization ||Stephen Spector, M.D.|
|Scott McCarty |
|Peripheral T-cell avidity/ exhaustion association with immunotherapy||Sandip Patel, M.D.|
|Erin Trovillion |
|Restoration of CD4+FoxP3+Regulatory T-cells and protection from chronic graft-versus host disease in pediatric patients depends on effective post-transplant thymopoiesis|
Edward Ball, M.D.